Statin Use Among Women and Men Following Coronary Artery Bypass Surgery
Open Access
- 1 April 2025
- journal article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (7) , e039011
Abstract
Background: Limited data exist on sex differences in guideline‐recommended statin therapy for secondary prevention after coronary artery bypass surgery (CABG). We examined sex differences in statin use after CABG and the association between sex‐specific statin use and mortality. Methods and Results: Data from the Austrian national cardiac surgery registry and federal social insurance claims database for patients who underwent CABG between 2013 and 2021 were used. Multivariable logistic regression models were calculated to obtain women‐to‐men odds ratios for filling any statin and high‐intensity statin prescriptions. Cox proportional hazards models were used to evaluate the association between statin use and mortality. A total of 15 448 patients (19% women) were included. During the 5 years after CABG, statin use decreased from 95.7% to 85.9% in men and 95.2% to 84.3% in women (P for trend P int =0.48), high‐intensity statin use decreased from 69.4% to 57.2% in men and 67.8% to 54.3% in women (P for trend P int =0.59). The adjusted odds ratio for filling any statin prescription comparing women with men was 1.03 (95% CI, 0.92–1.16) and for filling a high‐intensity statin prescription was 1.12 (95% CI, 1.02–1.23). Statin use was associated with a significantly lower mortality risk in both sexes (any statin: hazard ratio [HR], 0.56 [95% CI, 0.46–0.68]; P P int =0.22; high‐intensity statin: HR, 0.52 [95% CI, 0.42–0.63]; P P int =0.48). Conclusions: Women were as likely as men to fill a statin prescription after CABG and more likely to fill a high‐intensity prescription. Statin use was associated with a similar mortality risk reduction among women and men.Keywords
This publication has 19 references indexed in Scilit:
- Coronary Artery Bypass Graft Failure in WomenJACC, 2024
- Operative Outcomes of Women Undergoing Coronary Artery Bypass Surgery in the US, 2011 to 2020JAMA Surgery, 2023
- Statins for secondary prevention and major adverse events after coronary artery bypass graftingThe Journal of Thoracic and Cardiovascular Surgery, 2022
- Sex-Related Outcomes of Medical, Percutaneous, and Surgical Interventions for Coronary Artery DiseaseJACC, 2022
- Sex disparity in secondary prevention pharmacotherapy and clinical outcomes following acute coronary syndromeEuropean Heart Journal - Quality of Care and Clinical Outcomes, 2021
- Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016JAMA Network Open, 2020
- Sex Differences in High-Intensity Statin Use Following Myocardial Infarction in the United StatesJACC, 2018
- Trends in Use of High-Intensity Statin Therapy After Myocardial Infarction, 2011 to 2014JACC, 2017
- Meta-Analysis of Statin Effects in Women Versus MenJACC, 2012
- A SAS® macro for constructing simultaneous confidence intervals for multinomial proportionsComputer Methods and Programs in Biomedicine, 1997